Skip to Content

Lifeline Biotechnologies Inc LLBO

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Lifeline Biotechnologies Inc is an US-based company engaged in the business of developing and marketing technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. It has developed, tested, and patented a process that assists in the identification of dense breast tissue. The process is to be targeted as a screening protocol assisting in the early detection of breast tissue abnormalities and breast cancers.

1325 Airmotive Way, Suite 175
Reno, NV, 89502
T +1 775 852-3222
Sector Healthcare
Industry Medical Devices
Most Recent Earnings
Fiscal Year End Dec 31, 2015
Stock Type